DENVER--(BUSINESS WIRE)--EvoEndo ®, Inc. (“EvoEndo”), a medical device company developing systems for Unsedated Transnasal Endoscopy (TNE), is pleased to share recent decisions announced by the ...
Society High-grade dysplasia Low-grade dysplasia No dysplasia Ref. American Gastroenterological Association Definitive treatment EMR/ablation or surveillance every 3 months Repeat EGD in 6 months. If ...
REDMOND, Wash.--(BUSINESS WIRE)--EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), today announced the Federal Register has posted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback